130 related articles for article (PubMed ID: 1375507)
1. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.
Crutchley DJ; Solomon DE; Conanan LB
Arterioscler Thromb; 1992 Jun; 12(6):664-70. PubMed ID: 1375507
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.
Crutchley DJ; Conanan LB; Que BG
J Pharmacol Exp Ther; 1994 Oct; 271(1):446-51. PubMed ID: 7525928
[TBL] [Abstract][Full Text] [Related]
3. Effects of prostacyclin analogues on human endothelial cell tissue factor expression.
Crutchley DJ; Conanan LB; Toledo AW; Solomon DE; Que BG
Arterioscler Thromb; 1993 Jul; 13(7):1082-9. PubMed ID: 7686394
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells.
Wharton J; Davie N; Upton PD; Yacoub MH; Polak JM; Morrell NW
Circulation; 2000 Dec; 102(25):3130-6. PubMed ID: 11120706
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells.
Eisenhut T; Sinha B; Gröttrup-Wolfers E; Semmler J; Siess W; Endres S
Immunopharmacology; 1993; 26(3):259-64. PubMed ID: 7507098
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level.
Kainoh M; Maruyama I; Nishio S; Nakadate T
Biochem Pharmacol; 1991 Apr; 41(8):1135-40. PubMed ID: 1706920
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition by pentoxifylline of procoagulant activity produced by endotoxin-active monocytes].
de Prost D; Ollivier V; Hakim J
C R Seances Soc Biol Fil; 1992; 186(3):186-92. PubMed ID: 1283564
[TBL] [Abstract][Full Text] [Related]
8. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tumor necrosis factor alpha- and interleukin-1-beta-induced induced adhesion molecule expression in human vascular smooth muscle cells by cAMP.
Braun M; Pietsch P; Zepp A; Schrör K; Baumann G; Felix SB
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2568-75. PubMed ID: 9409229
[TBL] [Abstract][Full Text] [Related]
10. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins.
Sussmann M; Sarbia M; Meyer-Kirchrath J; Nüsing RM; Schrör K; Fischer JW
Circ Res; 2004 Mar; 94(5):592-600. PubMed ID: 14752026
[TBL] [Abstract][Full Text] [Related]
11. The stable prostacyclin analog, iloprost, and prostaglandin E1 inhibit monocyte procoagulant activity in vitro.
Crutchley DJ; Hirsh MJ
Blood; 1991 Jul; 78(2):382-6. PubMed ID: 1712648
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of endotoxin-induced cytotoxicity and prostacyclin production in cultured bovine pulmonary artery endothelial cells by phosphodiesterase inhibition.
Hussein A; Meyrick B; Graber S; Berry L; Brigham KL
Exp Lung Res; 1988; 14(5):637-54. PubMed ID: 2465143
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets.
Ashby B
Prostaglandins; 1992 Mar; 43(3):255-61. PubMed ID: 1378640
[TBL] [Abstract][Full Text] [Related]
14. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
15. Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.
Archipoff G; Beretz A; Bartha K; Brisson C; de la Salle C; Froget-Léon C; Klein-Soyer C; Cazenave JP
Br J Pharmacol; 1993 May; 109(1):18-28. PubMed ID: 7684300
[TBL] [Abstract][Full Text] [Related]
16. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins.
Schwaner I; Seifert R; Schultz G
Eicosanoids; 1992; 5 Suppl():S10-2. PubMed ID: 1280455
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism.
Ollivier V; Houssaye S; Ternisien C; Léon A; de Verneuil H; Elbim C; Mackman N; Edgington TS; de Prost D
Blood; 1993 Feb; 81(4):973-9. PubMed ID: 7679011
[TBL] [Abstract][Full Text] [Related]
18. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
Ashby B
Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function.
Wise H
Prostaglandins Leukot Essent Fatty Acids; 1996 May; 54(5):351-60. PubMed ID: 8832764
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects.
Tang DG; Grossi IM; Tang KQ; Diglio CA; Honn KV
Int J Cancer; 1995 Jan; 60(3):418-25. PubMed ID: 7530235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
